Type of lymphoma treatment impacts degree of harm to sperm

July 28, 2014
Type of lymphoma treatment impacts degree of harm to sperm
Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility.

(HealthDay)—Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility.

Louis Bujan, M.D., Ph.D., from Université de Toulouse in France, and colleagues compared sperm characteristics in 75 Hodgkin's lymphoma and non-Hodgkin's (before treatment and after three, six, 12, and 24 months) and a of 257 fertile men.

The researchers found that patients with no identified risk factor already had altered sperm characteristics before . After treatment, , total sperm count, motility, and vitality decreased, with lowest seen values at three and six months. Mean sperm count recovered to pretreatment values after doxorubicin, bleomycin, vinblastine, darcarbacine (ABVD) or ABVD + radiotherapy at 12 months after treatment, but not after doxorubicin, cyclophosphamide, vincristine, prednisone or mechlorethamine, oncovin, procarbazine, prednisone chemotherapies. At 24 months, 7 percent of patients remained azoospermic. Only pretreatment total sperm count was related to recovery in multivariate analyses, including diagnosis and treatment protocol.

"Lymphoma patients had altered sperm DNA and chromatin before treatment. Lymphoma treatment had damaging effects on spermatogenesis," the authors write. "These data on both the recovery period according to treatment modalities and the pre- and post-treatment chromatin status of sperm are useful tools for counseling patients wishing to conceive."

Explore further: Frozen testicle tissue yields healthy baby mice

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Frozen testicle tissue yields healthy baby mice

July 1, 2014

Sperm grown from the frozen testicle tissue of newborn mice has been used to produce healthy offspring, in a hopeful development for men left infertile by childhood cancer treatment, researchers said Tuesday.

HIV status doesn't influence Hodgkin's lymphoma outcome

October 11, 2012

(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, and dacarbazine ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.